Exhibit 99.1 McKESSON CORPORATION REPORTS FISCAL 2025 SECOND QUARTER RESULTS AND RAISES FULL YEAR ADJUSTED EPS GUIDANCE IRVING, Texas, November 6, 2024 - McKesson Corporation (NYSE:MCK) today announced results for the second quarter ended September 30, 2024. Second Quarter Highlights: • Consolidated revenues of $93.7 billion increased 21%. • Earnings per diluted share of $1.87 decreased $3.05. • Adjusted Earnings per Diluted Share of $7.07 increased 13%. • McKesson announced an agreement to acquire a contro ...

McKesson Corporation (MCK) is scheduled to report second-quarter fiscal 2025 results on Nov. 6, after market close.The company delivered an earnings surprise of 10.06% in the last reported quarter. Its earnings beat estimates in three of the trailing four quarters and missed once, delivering an average surprise of 4.82%.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.MCK’s top line has been gaining primarily on the back of the rapid adoption of GLP-1 weight loss drugs as well as con ...

In its upcoming report, McKesson (MCK) is predicted by Wall Street analysts to post quarterly earnings of $6.89 per share, reflecting an increase of 10.6% compared to the same period last year. Revenues are forecasted to be $89.48 billion, representing a year-over-year increase of 15.9%. The consensus EPS estimate for the quarter has been revised 0.3% higher over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates dur ...

McKesson (MCK) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price. The earnings report, which is expected to be released on November 6, 2024, might help the stock move higher if these key numbers are better than ...

McKesson (MCK) closed the most recent trading day at $508.95, moving +0.3% from the previous trading session. The stock's performance was ahead of the S&P 500's daily gain of 0.27%. Elsewhere, the Dow saw an upswing of 0.65%, while the tech-heavy Nasdaq appreciated by 0.26%.The the stock of prescription drug distributor has risen by 3.92% in the past month, leading the Medical sector's loss of 4.14% and the S&P 500's gain of 2%.Investors will be eagerly watching for the performance of McKesson in its upcomi ...

The latest trading session saw McKesson (MCK) ending at $513.67, denoting a +0.86% adjustment from its last day's close. The stock's change was more than the S&P 500's daily loss of 0.76%. Elsewhere, the Dow lost 0.75%, while the tech-heavy Nasdaq lost 1.01%.The prescription drug distributor's stock has dropped by 2.03% in the past month, exceeding the Medical sector's loss of 3.35% and lagging the S&P 500's gain of 4.31%.Investors will be eagerly watching for the performance of McKesson in its upcoming ear ...

I'm a value investor who enjoys using classical value ratios to pick my portfolio. Long-term focused on low P/B, P/FCF, Owner Earnings discounting, PEG ratios, the Graham Number and an occasional net-net hunter. I also believe tracking earnings growth versus price appreciation is an essential element to any quality evaluation.I advocate self-indexing primarily using the Dow Jones Industrial Average as my index of choice combined with Joel Greenblatt's Magic Formula. This can help with tax efficiency owning ...

McKesson (MCK) closed at $488.78 in the latest trading session, marking a -1.95% move from the prior day. This change lagged the S&P 500's daily gain of 0.01%. Elsewhere, the Dow saw an upswing of 0.09%, while the tech-heavy Nasdaq appreciated by 0.08%. The prescription drug distributor's shares have seen a decrease of 13.15% over the last month, not keeping up with the Medical sector's loss of 3.6% and the S&P 500's gain of 1.21%. The investment community will be paying close attention to the earnings perf ...

In the latest trading session, McKesson (MCK) closed at $479.06, marking a -0.02% move from the previous day. The stock's performance was behind the S&P 500's daily gain of 0.4%. Elsewhere, the Dow gained 0.62%, while the tech-heavy Nasdaq added 0.6%.Prior to today's trading, shares of the prescription drug distributor had lost 13.93% over the past month. This has lagged the Medical sector's loss of 2.27% and the S&P 500's gain of 1.71% in that time.Analysts and investors alike will be keeping a close eye o ...

McKesson (MCK) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.Over the past month, shares of this prescription drug distributor have returned -13.9%, compared to the Zacks S&P 500 composite's +1.7% change. During this period, the Zacks Medical - Dental Supplies industry, which McKesson falls in, has lost 2.8%. The key question now is: What could be the stock's future direction?While m ...